TMCnet News

Global Biosurgery Analysis and Market Forecast 2016-2022: Market Set to Reach $7.6 Billion as Technology Improves and Need Increases - Research and Markets
[October 20, 2016]

Global Biosurgery Analysis and Market Forecast 2016-2022: Market Set to Reach $7.6 Billion as Technology Improves and Need Increases - Research and Markets


Research and Markets has announced the addition of the "MediPoint: Biosurgery - Global Analysis and Market Forecast" report to their offering.

Prompt hemostasis, effective incision closure, tissue and vessel sealing, and post-operative adhesion prevention have been paramount concerns for surgeons for decades. As medical technology advances, the surgeon's toolbox expands to include more effective products that actively cease bleeding, close external and internal ruptures in tissue, and provide physical barriers between tissues to prevent dangerous adhesions. These biosurgery products have become indispensable keystones in any operating room environment.

Biosurgery products are experiencing steady growth across many countries. Emerging markets are expected to demonstrate the highest growth among the 15 market covered in the report, which are the US, Canada, Mexico, France, Germany, Italy, Spain, Russia, UK, Japan, China, India, South Korea, Australia, and Brazil.

The taxonomy of biosurgery included in this report covers hemostats, tissue sealants, tissue adhesives, and surgical adhesion barriers.

The global biosurgery market features two main players: J&J and Baxter.

Other prominent players include CryoLife, Sanofi, Pfizer, Integra LifeScences, C.R. Bard, and B. Braun.



The entire market will be driven by aging populations, higher volumes of surgical procedures, and an increasing number of technological innovations.

Key Opinion Leaders emphasize the need for better mechanical properties, optimal biocompatibility, and need for less expensive products.


Key Topics Covered:

1 Tables & Figures

2 Introduction

3 Market Access

3.1 Reimbursement

3.2 Regulation

3.3 Key Mergers, Acquisitions, Deals, and Partnerships

4 Unmet Needs

4.1 Overview

4.2 Optimal Mechanical Properties

4.3 Preparation and Storage

4.4 Safety Concerns

4.5 Better Biocompatibility

4.6 Emergency and Military Use of Hemostats

5 Competitive Assessment

5.1 Company Share Analysis

5.2 Major Players

5.3 Emerging Players

5.4 Distributors

6 Market Outlooks

6.1 Market Drivers and Barriers

6.2 Market Outlooks by Segment

6.3 Market Outlooks by Geography

6.4 Segment Share by Country

7 Appendix

Companies Mentioned

  • Advanced Medical Solutions
  • B. Braun
  • Atrium Medical
  • Baxter
  • C.R. Bard
  • CryoLife
  • Gelita
  • Sanofi
  • Integra LifeSciences
  • Ethicon Endo-Surgery (Johnson & Johnson)
  • Medtronic
  • Pfizer
  • Stryker
  • Takeda
  • 3-D Matrix Medical Technology
  • Adhezion Biomedical
  • Anika Therapeutics
  • BioActive Polymers
  • Chemence Medical
  • Cohera Medical
  • Gecko Biomedical
  • Hemostasis, LLC
  • HyperBranch Medical Technology
  • Mallinckrodt
  • Mast Biosurgery
  • OptMed
  • Sealantis
  • Vivostat

For more information about this report visit http://www.researchandmarkets.com/research/w64w2g/medipoint


[ Back To TMCnet.com's Homepage ]